What is HYFT stock price today?

HYFT (Mindwalk Holdings Corp) stock is trading at $1.28 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is HYFT stock going up or down today?

HYFT stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy HYFT stock now?

The decision to buy HYFT depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is HYFT a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for HYFT based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is HYFT stock overvalued or undervalued?

Use our DCF valuation calculator to determine if HYFT is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is HYFT's P/E ratio?

P/E ratio data for HYFT will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is HYFT's market cap?

HYFT (Mindwalk Holdings Corp) has a market capitalization of $0.06 billion, making it a small-cap stock.

What is HYFT's price to book ratio?

HYFT trades at a price-to-book (P/B) ratio of 5.15, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does HYFT pay dividends?

HYFT does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is HYFT's dividend yield?

HYFT does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is HYFT stock a good long-term investment?

HYFT's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is HYFT's revenue growth rate?

HYFT has shown revenue growth of 0.5% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

HYFT is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in HYFT?

Key risks for HYFT include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does HYFT compare to its competitors?

Compare HYFT to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize HYFT's performance and positioning.

What is HYFT's stock price target for 2026?

Our AI model provides price targets for HYFT based on fundamental analysis: Bull case $1.66 (+30%), Base case $1.47 (+15%), Bear case $1.15 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about HYFT?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for HYFT. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is HYFT's next earnings report?

HYFT reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

HYFT - Mindwalk Holdings Corp

NYSE * Healthcare * Biotechnology

$1.28

+$0.10 (+8.47%)

About Mindwalk Holdings Corp

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

HYFT Key Statistics

Market Cap

$55.12M

P/B Ratio

5.15

EPS

$-0.10

Revenue Growth

+0.5%

Profit Margin

-0.4%

Employees

How HYFT Compares to Peers

HYFT has the fastest revenue growth among competitors

HYFT is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
HYFT(This stock)	$55.12M	N/A	1%	-0.4%	-
AMGNAmgen Inc	$189.19B	24.7	0%	0.2%	vs AMGN
GILDGilead Sciences	$174.33B	20.7	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$113.01B	29.0	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.87B	18.2	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.50B	20.5	-0%	0.1%	vs BIIB

Mindwalk Holdings Corp Company Information

Headquarters: British Columbia; Canada
Website: www.mindwalkai.com
Sector: Healthcare
Industry: Biotechnology

About Mindwalk Holdings Corp

HYFT Key Statistics

How HYFT Compares to Peers

Mindwalk Holdings Corp Company Information

Upcoming Events for HYFT